Evrys Bio is a pharmaceutical company for providing health care solutions to defend against the virus.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Doylestown
State: Pennsylvania
Zip:
Country: United States
Evrys Bio was founded on breakthrough discoveries made at Princeton University. Whereas immuno-oncology drugs engage the patient’s immune system to fight cancer, Evrys Bio antivirals engage the cell’s intrinsic immunity to defend against infection. Evrys Bio’s vision is to develop first-in-class antivirals that are safe, address the problem of acquired drug-resistance, and provide unique broad-spectrum treatment options. This will transform the practice of medicine by addressing the infectious disease condition holistically as opposed to targeting a specific virus-type.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2016 | Seed Round | $347.5k | 1/2014 | Seed Round | $200k | 6/2016 | Venture Round | 1 | - |
Mid Atlantic Bio Angels Mid Atlantic Bio Angels |
7/2021 | Grant | 1 | $34.3M |
Defense Threat Reduction Agency (DTRA) Defense Threat Reduction Agency (DTRA) |
6/2016 | Venture Round | 1 | - |
Mid Atlantic Bio Angels Mid Atlantic Bio Angels |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|